Massachusetts Financial Services’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-55,649
Closed -$2.85M 879
2020
Q2
$2.85M Sell
55,649
-1,419
-2% -$59.4K ﹤0.01% 660
2020
Q1
$1.8M Buy
57,068
+9,032
+19% +$477K ﹤0.01% 692
2019
Q4
$2.86M Sell
48,036
-5,192
-10% -$233K ﹤0.01% 686
2019
Q3
$1.95M Buy
+53,228
New +$2.11M ﹤0.01% 721
2016
Q1
Sell
-133,074
Closed -$2.96M 846
2015
Q4
$2.96M Buy
133,074
+93,607
+237% +$2.36M ﹤0.01% 696
2015
Q3
$932K Sell
39,467
-22
-0.1% -$1.38K ﹤0.01% 762
2015
Q2
$3.23M Buy
39,489
+14,486
+58% +$1.42M ﹤0.01% 710
2015
Q1
$2.32M Buy
+25,003
New +$1.61M ﹤0.01% 733

Other funds holding ESPR